Advertisement

Topics

Latest "BioMarker Strategies LLC" News Stories - Page: 5

00:25 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "BioMarker Strategies LLC" found in our extensive news archives from over 250 global news sources.

More Information about BioMarker Strategies LLC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioMarker Strategies LLC for you to read. Along with our medical data and news we also list BioMarker Strategies LLC Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMarker Strategies LLC Companies for you to search.

Showing "BioMarker Strategies" News Articles 101–125 of 7,400+

Friday 15th March 2019

Cancer Biomarker for PARP Inhibitor Effectiveness Discovered

Since tumors often have unique defects in the DNA damage response (DDR) pathway, identifying the molecular mechanisms that underlie how cells repair various DNA lesions is critical to selecting the appropriate clinical treatments. Inhibitors to poly-(ADP-ribose) polymerase (PARP) are examples of drugs that successfully exploit the DDR pathway and have become an effective cancer therapy […] T...


Statement by FDA Commissioner Gottlieb on New Strategies to Modernize Clinical Trials to Advance Precision Medicine, Patient Protections and More Efficient Drug Development

Modernizing clinical trials is an agency wide priority. As more diseases are being redefined based on genomic subtype, researchers have more novel targets and more opportunities to precisely modulate or even repair the basic biological drivers of illness. Precision guided medicines can demonstrate strong efficacy signals in early clinical trials, including in trials where small …

How to Take a Headache History

Dr Deborah I. Friedman suggests strategies for arriving at a correct diagnosis when taking a headache history. American Headache Society and Medscape


Epigenomics AG: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 12:40 The issuer is solely responsible for the content of this announcement. Press release U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based t...

Epigenomics AG: U.S. Representatives Payne, Marchant, and Sewell Introduce Bi-Partisan Colorectal Cancer Detection Bill

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 12:40 The issuer is solely responsible for the content of this announcement. U.S. Representatives Payne, Marchant, and Sewell Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests ...

Vycellix CEO to Present Strategies for Enhancing Next-Generation NK Cell Cancer Therapy at Innate Killer Summit

Vycellix™, Inc. today announced that the Company, founded by leading medical researchers at Sweden’s world renowned Karolinska Institutet, will present at the Innate Killer Summit 2019 to be held in San Diego, March 20-21. On Wednesday, March 20th at 4:20pm PT, Vycellix’s founding CEO, Evren Alici, M.D., Ph.D. will present the session titled...

EMA Guide To Help Regulators Assess Subgroup Analyses In Confirmatory Trials

A new final guidance by the European Medicines Agency outlines broad principles and strategies that regulatory assessors can ...

Induction for Late-Term Pregnancies at 41 Weeks Tied to Small Benefits

FRIDAY, March 15, 2019 -- There may be a small benefit to labor induction in low-risk woman at 41 weeks versus expectant management, though the chances of a good perinatal outcome are high with both strategies, according to a study published online...

ArQule Announces Management Team Changes

ArQule, Inc. (Nasdaq: ARQL) today announced that Robert Weiskopf, Senior Vice President, Chief Financial Officer and Treasurer, has decided to retire effective March 29 of this year. In conjunction with Mr. Weiskopf’s departure, ArQule is naming Marc Schegerin, MD as Chief Financial Officer and Head of Strategy, effective as of Mr. Weiskopf’s retiremen...

New clinical development user's guide for kidney safety biomarkers

The Critical Path Institute's (C-Path) Predictive Safety Testing Consortium (PSTC) today announced availability of the User's Guide: Kidney Safety Composite Measure Biomarker for Use in Clinical Development.

Thursday 14th March 2019

[Articles] Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Globally, the burden of neurological disorders, as measured by the absolute number of DALYs, continues to increase. As populations are growing and ageing, and the prevalence of major disabling neurological disorders steeply increases with age, governments will face increasing demand for treatment, rehabilitation, and support services for neurological disorders. The scarcity of established modifiab...

SibFU researchers develop a biosensor enhanced with gold nanoparticles for express diagnostics of stress and toxicological pollution

(Siberian Federal University) A group of researchers is in the process of developing a highly sensitive biosensor designed to detect toxic substances using bioluminescent inhibitory analysis as well as to monitor a biomarker for indicating stress and cancer, namely heat shock proteins 90 (Hsp90).

Enzyme USP15 may have potential role in future treatment of various cancers

(George Washington University) A team at the George Washington University Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of pancreatic cancer, as well as ovarian and breast cancers.

SITC Guidelines Provide a Fresh Look at Evolving Strategies for Melanoma

New therapeutic approaches for treating patients with earlier-stage melanoma who face a higher risk of recurrence are among the features of recently updated consensus guidelines from the Society for Immunotherapy of Cancer.

ImmunogenX Initiates Phase 2 Trial for its Lead Therapeutic and Diagnostic Candidates Latiglutenase and CypCel

Both technologies address unmet needs for patients with celiac disease ImmunogenX is pleased to announce the initiation of a Phase 2 clinical trial (named Celiac Shield™), sponsored by the National Institutes of Health’s (NIH) National Center for Complementary and Integrative Health (NCCIH), to be conducted at the Mayo Clinic in Rochester, MN. The trial ...

Biodesix VeriStrat Data Demonstrate Independent Prediction of Immunotherapy Outcomes for NSCLC Patients

New Front-Line Data Presented at Multidisciplinary Thoracic Cancers Symposium Biodesix® today presented new data demonstrating that the VeriStrat® test is predictive of outcomes for patients with non-small

Large Trial Validates Detection of AR-V7 Biomarker Using Epic Sciences’ Platform to Predict Treatment Outcomes for Prostate Cancer Patients

SAN DIEGO, March 13, 2019 /PRNewswire/ — Epic Sciences, Inc. (Epic) today announced the publication of results from a multicenter prospective trial validating the biomarker AR-V7 (androgen receptor splice variant-7) as a predictor of resistance to anti-androgen therapy in men with metastatic castration-resistant prostate cancer (mCRPC). Data from the PROPHECY trial, published in the Journal ...

Pharmacy Times Continuing Education™ to Host Special Session on Pharmacists’ Roles in the Opioid Abuse Epidemic During Directions in Pharmacy® Meetings for Spring 2019

This session will feature video segments about a family dealing with the heartbreak of opioid addiction Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will host a special session during its ninth annual Directions in Pharmacy® continuing education confe...

#news #biotech New enzyme boosts ‘CRISPR toolbox’ for disease detection

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New enzyme boosts ‘CRISPR toolbox’ for disease detection .Mammoth Biosciences is harnessing CRISPR to create diagnostic tools that can detect any biomarker containing DNA or RNA, with the … Continue reading →

Does a Restrictive Blood Transfusion Strategy Improve Outcomes in Lower Gastrointestinal Bleeding?

Similar patient outcomes were seen with restrictive and liberal transfusion strategies.

SCC Soft Computer Welcomes SDS Pathology as a New Client

SCC Soft Computer (SCC) announced Specialist Diagnostic Services Pty Ltd (SDS Pathology), as a new client. SDS Pathology, the pathology division of Australian listed healthcare provider, Healius Limited, will be replacing their current system, Ultra (Triple G) with SCC’s Laboratory and Genetics Information Management Systems —including SCC’s...

Novel Therapeutics, Dosing Strategies Offer Hope in Metastatic Pancreatic Cancer

Given the poor prognosis of pancreatic cancer and the steady stream of negative phase III trials, clinicians are facing an uphill battle in the treatment of patients with metastatic pancreatic cancer.

Statement by FDA Commissioner Scott Gottlieb, M.D., on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development

FDA issues statement on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development

No End in Sight, Bladder Cancer Drug Shortage Takes a Toll

The immunotherapy BCG is in short supply in the United States. The American Urological Association and other groups have responded with a set of treatment strategies for clinicians, but problems are piling up. Medscape Medical News

Netsmart Welcomes Wendy Hill as First Chief People Officer

Netsmart announced today that Wendy Hill has been named the company’s first chief people officer (CPO). Hill will lead this new function that includes the human resources and associate development organization for the Kansas-headquartered healthcare IT provider. To accelerate the company’s focus on developing a people-first culture and ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks